notable speakers

Scientific Sessions

    • Pediatric Oncology
    • Pediatric Psychology
    • Pediatric Obesity & Nutrition
    • Pediatric Vaccines
    • Pediatric Infection & Allergy
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Sex hormone
    • Thyroid gland
    • Hypothyroidism
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Sex hormone
    • Thyroid gland
    • Hypothyroidism
    • Multiple endocrine neoplasias
    • Polycystic ovary syndrome
    • Corticosteroid
    • Graves Diseases
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Sex hormone
    • Thyroid gland
    • Hypothyroidism
    • Multiple endocrine neoplasias
    • Polycystic ovary syndrome
    • Corticosteroid
    • Graves Diseases
    • Prognostic marker
    • Diabetic nephropathy marker
    • Molecular marker for metabolic syndrome
    • Molecular Marker-Hypoglycaemic response
    • Inflammatory markers: Type 2 diabetes
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Sex hormone
    • Thyroid gland
    • Hypothyroidism
    • Multiple endocrine neoplasias
    • Polycystic ovary syndrome
    • Corticosteroid
    • Graves Diseases
    • Prognostic marker
    • Diabetic nephropathy marker
    • Molecular marker for metabolic syndrome
    • Molecular Marker-Hypoglycaemic response
    • Inflammatory markers: Type 2 diabetes
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Sex hormone
    • Thyroid gland
    • Hypothyroidism
    • Multiple endocrine neoplasias
    • Polycystic ovary syndrome
    • Corticosteroid
    • Graves Diseases
    • Prognostic marker
    • Diabetic nephropathy marker
    • Molecular marker for metabolic syndrome
    • Molecular Marker-Hypoglycaemic response
    • Inflammatory markers: Type 2 diabetes
    • Epidemiology
    • Osteoporosis and Estrogen
    • Osteoporosis and Osteoarthritis
    • Osteoporosis and Osteomalacia
    • Osteoporosis and Periodontal disease
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Sex hormone
    • Thyroid gland
    • Hypothyroidism
    • Multiple endocrine neoplasias
    • Polycystic ovary syndrome
    • Corticosteroid
    • Graves Diseases
    • Prognostic marker
    • Diabetic nephropathy marker
    • Molecular marker for metabolic syndrome
    • Molecular Marker-Hypoglycaemic response
    • Inflammatory markers: Type 2 diabetes
    • Epidemiology
    • Osteoporosis and Estrogen
    • Osteoporosis and Osteoarthritis
    • Osteoporosis and Osteomalacia
    • Osteoporosis and Periodontal disease
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Sex hormone
    • Thyroid gland
    • Hypothyroidism
    • Multiple endocrine neoplasias
    • Polycystic ovary syndrome
    • Corticosteroid
    • Graves Diseases
    • Prognostic marker
    • Diabetic nephropathy marker
    • Molecular marker for metabolic syndrome
    • Molecular Marker-Hypoglycaemic response
    • Inflammatory markers: Type 2 diabetes
    • Epidemiology
    • Osteoporosis and Estrogen
    • Osteoporosis and Osteoarthritis
    • Osteoporosis and Osteomalacia
    • Osteoporosis and Periodontal disease
    • Obstetrics
    • Gynaecology
    • Infertility
    • Female endocrinology
    • Male Endocrinology
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Sex hormone
    • Thyroid gland
    • Hypothyroidism
    • Multiple endocrine neoplasias
    • Polycystic ovary syndrome
    • Corticosteroid
    • Graves Diseases
    • Prognostic marker
    • Diabetic nephropathy marker
    • Molecular marker for metabolic syndrome
    • Molecular Marker-Hypoglycaemic response
    • Inflammatory markers: Type 2 diabetes
    • Epidemiology
    • Osteoporosis and Estrogen
    • Osteoporosis and Osteoarthritis
    • Osteoporosis and Osteomalacia
    • Osteoporosis and Periodontal disease
    • Obstetrics
    • Gynaecology
    • Infertility
    • Female endocrinology
    • Male Endocrinology
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Sex hormone
    • Thyroid gland
    • Hypothyroidism
    • Multiple endocrine neoplasias
    • Polycystic ovary syndrome
    • Corticosteroid
    • Graves Diseases
    • Prognostic marker
    • Diabetic nephropathy marker
    • Molecular marker for metabolic syndrome
    • Molecular Marker-Hypoglycaemic response
    • Inflammatory markers: Type 2 diabetes
    • Epidemiology
    • Osteoporosis and Estrogen
    • Osteoporosis and Osteoarthritis
    • Osteoporosis and Osteomalacia
    • Osteoporosis and Periodontal disease
    • Obstetrics
    • Gynaecology
    • Infertility
    • Female endocrinology
    • Male Endocrinology
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Sex hormone
    • Thyroid gland
    • Hypothyroidism
    • Multiple endocrine neoplasias
    • Polycystic ovary syndrome
    • Corticosteroid
    • Graves Diseases
    • Prognostic marker
    • Diabetic nephropathy marker
    • Molecular marker for metabolic syndrome
    • Molecular Marker-Hypoglycaemic response
    • Inflammatory markers: Type 2 diabetes
    • Epidemiology
    • Osteoporosis and Estrogen
    • Osteoporosis and Osteoarthritis
    • Osteoporosis and Osteomalacia
    • Osteoporosis and Periodontal disease
    • Obstetrics
    • Gynaecology
    • Infertility
    • Female endocrinology
    • Male Endocrinology
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Sex hormone
    • Thyroid gland
    • Hypothyroidism
    • Multiple endocrine neoplasias
    • Polycystic ovary syndrome
    • Corticosteroid
    • Graves Diseases
    • Prognostic marker
    • Diabetic nephropathy marker
    • Molecular marker for metabolic syndrome
    • Molecular Marker-Hypoglycaemic response
    • Inflammatory markers: Type 2 diabetes
    • Epidemiology
    • Osteoporosis and Estrogen
    • Osteoporosis and Osteoarthritis
    • Osteoporosis and Osteomalacia
    • Osteoporosis and Periodontal disease
    • Obstetrics
    • Gynaecology
    • Infertility
    • Female endocrinology
    • Male Endocrinology
    • Endocrinology and Metabolism
    • sexual dysfunction
    • Hormone-related disorders
    • Diabetes Ophthalmology
    • Types of Diabetes
    • Gestational diabetes (GDM)
    • Type 1 diabetes
    • Type 2 Diabetes
    • Endocrine Glands
    • Endocrine Hormones
    • Nervous System
    • Hypothalamus
    • Immune system
    • Reproductive system
    • Sex hormone
    • Thyroid gland
    • Hypothyroidism
    • Multiple endocrine neoplasias
    • Polycystic ovary syndrome
    • Corticosteroid
    • Graves Diseases
    • Prognostic marker
    • Diabetic nephropathy marker
    • Molecular marker for metabolic syndrome
    • Molecular Marker-Hypoglycaemic response
    • Inflammatory markers: Type 2 diabetes
    • Epidemiology
    • Osteoporosis and Estrogen
    • Osteoporosis and Osteoarthritis
    • Osteoporosis and Osteomalacia
    • Osteoporosis and Periodontal disease
    • Obstetrics
    • Gynaecology
    • Infertility
    • Female endocrinology
    • Male Endocrinology

About / Welcome Message

Welcome Message

Welcome Message

About Conference

 Theme: Commitment to Excellence in the field of Diabetes and Endocrinology

ME Conference invite all participants to “3rd Global Diabetes Summit” which is scheduled during, July 15-16, 2020 at Helsinki, Finland which includes prompt keynote presentations, Oral talks, Poster presentations, and Exhibitions.ME Conference series through its open access initiative is committed to making a genuine and reliable offering to the scientific community and to the world. This conference centralized around the theme ”Commitment to Excellence in the field of Diabetes and Endocrinology

Our conference can review the major event in developing, upgrading and teaching Endocrinology, Diabetes, thyroid, reproduction and Metabolic Syndromes. Our Event strongly initiated by the possibilities offered in the field by cellular endocrinology and by the progress taking place in clinical biochemistry and experimental pharmacology, which can be reviewed by our World Congress. In the same way, the development leading in the field of clinical trials, and large meta-analysis will lead us to understand the possibilities, limits, risks, and advantages of our therapies and diagnostic approaches taking place in the field of diabetes and endocrinology.

Endocrinology is defined as a branch of biological science that mainly deals with the study of the endocrine system and related functions, secretions, and diseases. The endocrine system contains various glands which have its own secretion, known as the hormone that performs specific functions.

Target Audience

Endocrinology Meet 2020 welcome the Scientists, Doctors, Academician, Researchers, Students, Business Entrepreneurs, etc. related to the wide areas of Diabetes, Endocrinology, Medical and Health care, Diabetes and Endocrinology organizations are most likely to attend World Endocrinology Congress 2020  and utilize the scope of extending their skills, and their work on basic and significant applications in the Various field of Endocrinology. The World Endocrinology Congress 2020 conference will be useful to participants from both the Industry and Academia working in all the domains of Health care sectors, all other target audience includes:

  • Researchers
  • Scientists
  • Health care experts
  • Diabetologists
  • Endocrinologists
  • Cardiologists
  • Nephrologists
  • Nutritionists/Dieticians
  • Diabetes Health Professionals
  • Physicians
  • Nurse practitioners
  • Health care analysts
  • Doctors
  • Academic researchers
  • Professors
  • Students
  • Research Institutes
  • Business delegates
  • Young Researchers
  • Advertising and Promotion Agency Executives
  • Professionals in media sector
  • Medical colleges
  • Diabetes Societies & Associations
  • Obesity Societies & Associations
  • Heart Societies & Associations
  • Medical & Pharmaceutical Companies
  • Medical devices & companies
  • Others

Why to attend???

Medical doctors, patients, and health care providers consider the prevention of Endocrinology and Metabolic diabetes as an essential tool to improve the general health status of the population. The proportions of people suffering from the Endocrinology and diabetes are expected to increase in the future according to a recent statistical survey. Realizing this imperative, Conference Series Ltd is set to organize International Conference on 2nd World Congress on Endocrinology and Diabetes and for the upcoming year with a view to intensify research and to promote awareness in developing solutions for the challenges encountered in this field..

Benefits of Attending:

  • Exchange of ideas and research with leading, endocrinologists, diabetes researchers, clinician’s scientists, diabetes and endocrinology professionals and researchers from more than 40 countries.
  • Discuss quality initiatives that can be applied in the practice.
  • Novel process to collaborate in putting quality initiatives in place throughout the Endocrinology and Diabetes study and endocrinology and diabetes disorders and treatment.
  • Participants can gain direct, blaze to a core audience of professionals and decision-makers and can increase visibility in the field of endocrinology and diabetes through branding and networking at the conference.
  • Learn and discuss key topics and challenges with senior level speakers at the conference site.
  • With presentations, panel discussions, and workshops, we cover every topic regarding the conference from top to bottom, an excellent platform to showcase the latest products and formulation in the field of endocrinology and diabetes.

 Theme: Commitment to Excellence in the field of Diabetes and Endocrinology

ME Conference invite all participants to “3rd Global Diabetes Summit” which is scheduled during, July 15-16, 2020 at Helsinki, Finland which includes prompt keynote presentations, Oral talks, Poster presentations, and Exhibitions.ME Conference series through its open access initiative is committed to making a genuine and reliable offering to the scientific community and to the world. This conference centralized around the theme ”Commitment to Excellence in the field of Diabetes and Endocrinology

Our conference can review the major event in developing, upgrading and teaching Endocrinology, Diabetes, thyroid, reproduction and Metabolic Syndromes. Our Event strongly initiated by the possibilities offered in the field by cellular endocrinology and by the progress taking place in clinical biochemistry and experimental pharmacology, which can be reviewed by our World Congress. In the same way, the development leading in the field of clinical trials, and large meta-analysis will lead us to understand the possibilities, limits, risks, and advantages of our therapies and diagnostic approaches taking place in the field of diabetes and endocrinology.

Endocrinology is defined as a branch of biological science that mainly deals with the study of the endocrine system and related functions, secretions, and diseases. The endocrine system contains various glands which have its own secretion, known as the hormone that performs specific functions.

Target Audience

Endocrinology Meet 2020 welcome the Scientists, Doctors, Academician, Researchers, Students, Business Entrepreneurs, etc. related to the wide areas of Diabetes, Endocrinology, Medical and Health care, Diabetes and Endocrinology organizations are most likely to attend World Endocrinology Congress 2020  and utilize the scope of extending their skills, and their work on basic and significant applications in the Various field of Endocrinology. The World Endocrinology Congress 2020 conference will be useful to participants from both the Industry and Academia working in all the domains of Health care sectors, all other target audience includes:

  • Researchers
  • Scientists
  • Health care experts
  • Diabetologists
  • Endocrinologists
  • Cardiologists
  • Nephrologists
  • Nutritionists/Dieticians
  • Diabetes Health Professionals
  • Physicians
  • Nurse practitioners
  • Health care analysts
  • Doctors
  • Academic researchers
  • Professors
  • Students
  • Research Institutes
  • Business delegates
  • Young Researchers
  • Advertising and Promotion Agency Executives
  • Professionals in media sector
  • Medical colleges
  • Diabetes Societies & Associations
  • Obesity Societies & Associations
  • Heart Societies & Associations
  • Medical & Pharmaceutical Companies
  • Medical devices & companies
  • Others

Why to attend???

Medical doctors, patients, and health care providers consider the prevention of Endocrinology and Metabolic diabetes as an essential tool to improve the general health status of the population. The proportions of people suffering from the Endocrinology and diabetes are expected to increase in the future according to a recent statistical survey. Realizing this imperative, Conference Series Ltd is set to organize International Conference on 2nd World Congress on Endocrinology and Diabetes and for the upcoming year with a view to intensify research and to promote awareness in developing solutions for the challenges encountered in this field..

Benefits of Attending:

  • Exchange of ideas and research with leading, endocrinologists, diabetes researchers, clinician’s scientists, diabetes and endocrinology professionals and researchers from more than 40 countries.
  • Discuss quality initiatives that can be applied in the practice.
  • Novel process to collaborate in putting quality initiatives in place throughout the Endocrinology and Diabetes study and endocrinology and diabetes disorders and treatment.
  • Participants can gain direct, blaze to a core audience of professionals and decision-makers and can increase visibility in the field of endocrinology and diabetes through branding and networking at the conference.
  • Learn and discuss key topics and challenges with senior level speakers at the conference site.
  • With presentations, panel discussions, and workshops, we cover every topic regarding the conference from top to bottom, an excellent platform to showcase the latest products and formulation in the field of endocrinology and diabetes.

Sessions / Tracks

View More..

Market Analysis

Call for proposals are open for oral papers, panel presentations and scientific posters across the list of tracks highlighted in our website and papers on other topics not listed or present in the website are also welcome if they meet the objectives of the conference. We hope and expect the  Diabetes Summit 2020theme to inspire a number of people all around the globe, research avenues and look forward to discussing ideas, findings, and synergies, in this International Academic Forum which is going to be held at The Netherland on April 20-21, 2020.

Growing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency are predicted to boost the demand for endocrine testing. The growing diabetic, geriatric and obese population worldwide is expected to promote market growth. Furthermore, growing healthcare awareness among individuals coupled with increasing government support is expected to increase the diagnosis at an early, thereby contributing to the growth of the endocrine testing market.

Owing to increasing health awareness around the world, there has been an advancement in-home health care along with easy operating home diagnostic kits which are cost-effective and designed with precision. Many new mass spectrometric technologies have been developed all around the globe which delivers accurate results in less time and they are highly sensitive. Mass Spectrometry is now coupled with liquid chromatography for more precision. Telehealth services have also been introduced by some commercial laboratories and stand-alone clinics.

Based on test type, the market is segmented into Estradiol (E2), Human Chorionic Gonadotropin (HCG), Follicle Stimulating (FSH), Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH), testosterone, thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and other tests are also present such as gastrin, thymosin, and secretin tests.

Thyroid-stimulating hormone (TSH) test accounted for a lucrative share in 2016, This can be attributed to the increasing incidences of TSH-related disorders and the growing awareness regarding the correlation between variations in the thyroid hormones levels and cardiovascular disorders.

Insulin test is anticipated to witness one of the fastest growths over the forecast period all over the world. The substantial rise in the diabetic population and the growing awareness about diagnosis are anticipated to contribute towards the demand for insulin test over the forecast period.

Key technology segments include tandem mass spectrometry, immunoassay, monoclonal & polyclonal antibody technologies, sensors, clinical chemistry technologies, and others such as Liquid Chromatography with Mass Spectrometry (LC-MS).

The tandem mass spectrometry is expected to dominate all over the world market during the forecast period. This can be attributed to the growing use of tandem mass spectrometry in combination with liquid chromatography which helps in overcoming the challenges associated with traditional techniques used for endocrine testing.

Sensor Technology is expected to show the fastest growth among all the segments owing to the growing use of biosensors in glucose monitoring for diabetes which is used on a routine basis by the individuals to monitor their blood sugar level in undiluted blood samples.

The major share in endocrine testing market share is held by companies such as Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, Biomerieux SA, Bio-Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., Lab Corp, and Quest Diagnostics.

The players are actively involved in launching technologically advanced products and initiate collaborative developments to sustain themselves in the competition. For instance, Lab Corp offers all-embracing solutions on clinical trials pertaining to diabetes and all other hormonal diseases. In addition, the company also provides liquid chromatography that combined with mass spectrometry to yield specific results even if the minimal amounts of the hormonal sample are present.

Scope and Importance

Endocrinology and Diabetes is a branch of science dealing with the endocrine glands and related disorders and a metabolic disorder deals with abnormal chemical reactions in the body alter the normal metabolic process. Endocrinology includes the study of hormones, the endocrine system, and their role in the physiology of the body. Endocrinology is a department of medicine which manages with the diagnosis and treatment of diseases which are usually related to hormones and also diagnostic evaluation of a wide variety of symptoms and variations and the long-term management of disorders which are caused due to deficiency or excess of one or more hormones. Diabetes mellitus commonly known as diabetes referred a group of metabolic disorders which includes high blood sugar levels over a prolonged period of time. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger fatigue. If left untreated, diabetes can cause many complications. A metabolic disorder can occur when irregular chemical reactions in the body altering the normal metabolic pathway. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive disorders.

Societies associated with Endocrinology research

  • Endocrine Society
  • American Association of Clinical Endocrinologists
  • The American Association of Endocrine Surgeons
  • Association of Program Directors in Endocrinology, Diabetes and Metabolism
  • Society for Endocrinology
  • Brazilian Society of Surgical Endocrinology
  • British Society for Pediatric Endocrinology and Diabetes
  • European Society of Endocrinology
  • International Society of Endocrinology
  • Pediatric Endocrine Society   
  • SBDR - Society for Biomedical Diabetes Research
  • Austrian Diabetes Association
  • Flemish Diabetes Association
  • Association of Juvenile Diabetes
  • Canadian Diabetes Association
  • Juvenile Diabetes Foundation of Chile
  • German Diabetes Union
  • Diabetic Society of Singapore
  • Japan Diabetes Society
  • Hong Kong Diabetes Federation
  • The International Society of Gynaecological Endocrinology
  • Royal Society of Medicine Endocrinology and Diabetes Section
  • International Society of Psych neuroendocrinology
  • International Neuroendocrine Federation
  • European Society of Endocrinology
  • Clinical Endocrinology Trust
  • Swiss Diabetes Society
  • Spanish Diabetes Society
  • Korean Diabetes Association

Global companies related to diabetes

  • Novo Nordisk
  • Eli Lilly
  • Sanofi
  • Merck & Co
  • Astra Zeneca
  • Boehringer Ingelheim
  • Johnson Health Tech. Co., Ltd.
  • Novartis
  • Takeda
  • Johnson Health Tech. Co., Ltd.
  • Bayer

 

Call for proposals are open for oral papers, panel presentations and scientific posters across the list of tracks highlighted in our website and papers on other topics not listed or present in the website are also welcome if they meet the objectives of the conference. We hope and expect the  Diabetes Summit 2020theme to inspire a number of people all around the globe, research avenues and look forward to discussing ideas, findings, and synergies, in this International Academic Forum which is going to be held at The Netherland on April 20-21, 2020.

Growing incidences of endocrine disorders such as hyperthyroidism and adrenal insufficiency are predicted to boost the demand for endocrine testing. The growing diabetic, geriatric and obese population worldwide is expected to promote market growth. Furthermore, growing healthcare awareness among individuals coupled with increasing government support is expected to increase the diagnosis at an early, thereby contributing to the growth of the endocrine testing market.

Owing to increasing health awareness around the world, there has been an advancement in-home health care along with easy operating home diagnostic kits which are cost-effective and designed with precision. Many new mass spectrometric technologies have been developed all around the globe which delivers accurate results in less time and they are highly sensitive. Mass Spectrometry is now coupled with liquid chromatography for more precision. Telehealth services have also been introduced by some commercial laboratories and stand-alone clinics.

Based on test type, the market is segmented into Estradiol (E2), Human Chorionic Gonadotropin (HCG), Follicle Stimulating (FSH), Dehydroepiandrosterone sulfate (DHEAS), Progesterone, Luteinizing Hormone (LH), testosterone, thyroid prolactin, Thyroid Stimulating Hormone (TSH), cortisol, insulin, and other tests are also present such as gastrin, thymosin, and secretin tests.

Thyroid-stimulating hormone (TSH) test accounted for a lucrative share in 2016, This can be attributed to the increasing incidences of TSH-related disorders and the growing awareness regarding the correlation between variations in the thyroid hormones levels and cardiovascular disorders.

Insulin test is anticipated to witness one of the fastest growths over the forecast period all over the world. The substantial rise in the diabetic population and the growing awareness about diagnosis are anticipated to contribute towards the demand for insulin test over the forecast period.

Key technology segments include tandem mass spectrometry, immunoassay, monoclonal & polyclonal antibody technologies, sensors, clinical chemistry technologies, and others such as Liquid Chromatography with Mass Spectrometry (LC-MS).

The tandem mass spectrometry is expected to dominate all over the world market during the forecast period. This can be attributed to the growing use of tandem mass spectrometry in combination with liquid chromatography which helps in overcoming the challenges associated with traditional techniques used for endocrine testing.

Sensor Technology is expected to show the fastest growth among all the segments owing to the growing use of biosensors in glucose monitoring for diabetes which is used on a routine basis by the individuals to monitor their blood sugar level in undiluted blood samples.

The major share in endocrine testing market share is held by companies such as Abbott Laboratories, AB Sciex, Agilent Technologies, Biomedical Technologies, Biomerieux SA, Bio-Rad Laboratories, DiaSorin, Hoffmann-La Roche Ltd., Lab Corp, and Quest Diagnostics.

The players are actively involved in launching technologically advanced products and initiate collaborative developments to sustain themselves in the competition. For instance, Lab Corp offers all-embracing solutions on clinical trials pertaining to diabetes and all other hormonal diseases. In addition, the company also provides liquid chromatography that combined with mass spectrometry to yield specific results even if the minimal amounts of the hormonal sample are present.

Scope and Importance

Endocrinology and Diabetes is a branch of science dealing with the endocrine glands and related disorders and a metabolic disorder deals with abnormal chemical reactions in the body alter the normal metabolic process. Endocrinology includes the study of hormones, the endocrine system, and their role in the physiology of the body. Endocrinology is a department of medicine which manages with the diagnosis and treatment of diseases which are usually related to hormones and also diagnostic evaluation of a wide variety of symptoms and variations and the long-term management of disorders which are caused due to deficiency or excess of one or more hormones. Diabetes mellitus commonly known as diabetes referred a group of metabolic disorders which includes high blood sugar levels over a prolonged period of time. Symptoms of high blood sugar include frequent urination, increased thirst, and increased hunger fatigue. If left untreated, diabetes can cause many complications. A metabolic disorder can occur when irregular chemical reactions in the body altering the normal metabolic pathway. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive disorders.

Societies associated with Endocrinology research

  • Endocrine Society
  • American Association of Clinical Endocrinologists
  • The American Association of Endocrine Surgeons
  • Association of Program Directors in Endocrinology, Diabetes and Metabolism
  • Society for Endocrinology
  • Brazilian Society of Surgical Endocrinology
  • British Society for Pediatric Endocrinology and Diabetes
  • European Society of Endocrinology
  • International Society of Endocrinology
  • Pediatric Endocrine Society   
  • SBDR - Society for Biomedical Diabetes Research
  • Austrian Diabetes Association
  • Flemish Diabetes Association
  • Association of Juvenile Diabetes
  • Canadian Diabetes Association
  • Juvenile Diabetes Foundation of Chile
  • German Diabetes Union
  • Diabetic Society of Singapore
  • Japan Diabetes Society
  • Hong Kong Diabetes Federation
  • The International Society of Gynaecological Endocrinology
  • Royal Society of Medicine Endocrinology and Diabetes Section
  • International Society of Psych neuroendocrinology
  • International Neuroendocrine Federation
  • European Society of Endocrinology
  • Clinical Endocrinology Trust
  • Swiss Diabetes Society
  • Spanish Diabetes Society
  • Korean Diabetes Association

Global companies related to diabetes

  • Novo Nordisk
  • Eli Lilly
  • Sanofi
  • Merck & Co
  • Astra Zeneca
  • Boehringer Ingelheim
  • Johnson Health Tech. Co., Ltd.
  • Novartis
  • Takeda
  • Johnson Health Tech. Co., Ltd.
  • Bayer

 

View More..

Past Conference Report

View More..

Our Partners

$partners['imageshow']; ?>
$partners['imageshow']; ?>
$partners['imageshow']; ?>
$partners['imageshow']; ?>
$partners['imageshow']; ?>
$partners['imageshow']; ?>
$partners['imageshow']; ?>
$partners['imageshow']; ?>
$partners['imageshow']; ?>

Impressions of Pediatric Conferences

Scientific Programs

Supporting Journals

Abstracts will be provided with Digital Object Identifier by Crossref

Testimonials